COMPARE · Data as of August 27, 2026
CM vs SAN
Verdict: Side-by-side breakdown using the Bull Rankings model. CM scored 74.0, SAN scored 66.0 — CM leads.
Compare another set
CM
Canadian Imperial Bank of Commerce
62.7Fin
$114.84 · $104.3B
fundamentals as of
Strength gap
0.8
CM leads
SAN
Banco Santander, S.A.
61.9Fin
$14.55 · $211.5B
At a glance · who leads each dimension, on the model's own rules
- CheapestSAN14.1x
- Fastest growthCM+13.7%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
CM
SAN
+13.7%B+
Rev
-0.5%D+
15.8xC+
P/E
14.1xB
15.4%B+
ROE
13.1%B
2.27C+
P/B
1.63B
2.6%B
Yield
1.9%C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
CMCanadian Imperial Bank of Commerce
Why now
Banks - Diversified · market cap $104.3b. 8% off the 52-week high of $124.86. Revenue growing +14%, comfortably above the S&P median. 3 sell-side analysts rate this a Buy with a mean 1-yr target of $118.90 (implying +4% upside).
Moat
Net margin 34% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 15% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. $104.3b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
SANBanco Santander, S.A.
Why now
Banks - Diversified · market cap $211.5b. Trading near 52-week high of $15.00 — momentum setup, limited technical margin of safety. 3 sell-side analysts rate this a Hold with a mean 1-yr target of $13.56 (implying -7% upside).
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. $211.5b market cap places it among the largest companies in the sector — distribution, R&D, and customer-acquisition costs amortize across a base peers can't replicate.
Risk
Trading within 3% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.